Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus documentMarieke Biegstraaten, Carla E. M. Hollak, Reynir Arngrı́msson et al.|Orphanet Journal of Rare Diseases|2015Cited by 345
IRF2BPL Is Associated with Neurological PhenotypesPaul C. Marcogliese, Wim Terryn, Vandana Shashi et al.|The American Journal of Human Genetics|2018Cited by 115
Chronic kidney disease and an uncertain diagnosis of Fabry disease: Approach to a correct diagnosisLinda van der Tol, Gabor E. Linthorst, Stephen Waldek et al.|Molecular Genetics and Metabolism|2014Cited by 64